ImmunityBio Director Simon Barry J. Sells Nearly 152,000 Shares Under Rule 10b5‑1 Plan, While Company Stocks Soar to 52‑Week Highs.
Simon Barry J. sells 151,967 ImmunityBio shares via a Rule 10b5‑1 plan—insider liquidity, not loss of confidence, amid a 203% rally and strong oncology pipeline.
3 minutes to read